Napo Pharmaceuticals

About:

Napo Pharmaceuticals develops and commercializes proprietary pharmaceuticals in collaboration with local partners.

Website: http://napopharma.com

Twitter/X: napopharma

Top Investors: Jaguar Health, Kingdon Capital, SPRIM Ventures

Description:

Napo Pharmaceuticals, Inc. develops and commercializes proprietary pharmaceuticals for international markets. It offers Crofelemer for gastrointestinal indications, including chronic diarrhea in persons living with HIV/AIDS; and NP-500, a product for insulin-resistant diseases. The company also provides CRO-IBS for diarrhea-predominant IBS; CRO-HIV for AIDS-related diarrhea; CRO-ID for acute infectious diarrhea; and CRO-PED for pediatric diarrhea. It offers its products for D-IBS, HIV, acute-cholera, and pediatric markets. The company was founded in 2001 and is based in San Francisco, California. It has a subsidiary location in Mumbai, India.